<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-04-19</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38638124/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Greater Disease Severity and Worse Clinical Outcomes in Patients Hospitalised with COVID-19 in Africa</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38638124-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Overall, hospitalised African patients with COVID-19 had a higher mortality despite a lower mean age, contradicting literature that had previously reported a lower mortality attributed to COVID-19 in Africa. African sites had lower COVID-19 vaccination rates and higher AKI rates, which were positively associated with increased mortality. In conclusion, African patients were hospitalized with more severe COVID-19 cases and had poorer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38638148/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Small fibre neuropathy in Fabry disease: a human-derived neuronal &lt;em&gt;in vitro&lt;/em&gt; disease model and pilot data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38638148-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Acral burning pain triggered by fever, thermal hyposensitivity and skin denervation are hallmarks of small fibre neuropathy in Fabry disease, a life-threatening X-linked lysosomal storage disorder. Variants in the gene encoding alpha-galactosidase A may lead to impaired enzyme activity with cellular accumulation of globotriaosylceramide. To study the underlying pathomechanism of Fabry-associated small fibre neuropathy, we generated a neuronal in vitro disease model using patient-derived &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639017/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation &amp;amp; Right Ventricular Function</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639017-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Pulmonary hypertension (PH) associated with left heart failure (LHF) (PH-LHF) is one of the most common causes of PH. It directly contributes to symptoms and reduced functional capacity and negatively affects right heart function, ultimately leading to a poor prognosis. There are no specific treatments for PH-LHF, despite the high number of drugs tested so far. This scientific document addresses the main knowledge gaps in PH-LHF with emphasis on pathophysiology and clinical trials. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639359/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Design, Rationale and Initial Findings From HERA-FIB on 10 222 Patients With Atrial Fibrillation Presenting to an Emergency Department Over An 11-Year Period</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639359-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: HERA-FIB is one of the largest real-world single-center retrospective registries on patients with AF, which captures the era of transition from vitamin K antagonists to non-vitamin K oral anticoagulation regimens in clinical practice and offers the possibility to investigate patient populations usually underrepresented or excluded in current available randomized controlled trials and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639410/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240419180734&amp;v=2.18.0.post9&#43;e462414">Increasing Firearm-Related Deaths among U.S. Black Rural Youths</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639410-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240419180734-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639475/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Heparan Sulfates and Heparan Sulfate Proteoglycans in Hematopoiesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639475-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    From signaling mediators in stem cells, to markers of differentiation and lineage commitment, to facilitators for the entry of viruses like HIV-1, cell surface heparan sulfate (HS) glycans with their distinct modification patterns play important roles in hematopoietic biology. In this review, we provide an overview of the importance of HS and the proteoglycans (HSPGs) to which they are attached, within the major cellular subtypes of the hematopoietic system. We summarize the roles of HSPGs, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639537/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Location-Selective Work Function Engineering by Self-Assembled Monolayers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639537-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Control over specific interfaces in devices represents a key challenge for modern organic electronics and photovoltaics. Such control is frequently gained by the use of self-assembled monolayers (SAMs), which, by selection of a proper anchoring group, are generally discriminative with respect to different materials but are not selective between different areas of the same material. In particular, selective tailoring of the work function may be useful for different functional devices in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639766/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Cord-like induration on the lower leg</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639766-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639767/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Selected aspects regarding social factors in skin diseases</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639767-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Skin diseases are complex and cannot be explained solely by genetic or environmental factors but are also significantly shaped by social influences. This review illuminates the bidirectional relationship between social factors and skin diseases, demonstrating how social determinants such as socioeconomic status, living environment, and psychosocial stress can influence the onset and progression of skin conditions. Simultaneously, it explores how skin diseases can affect individuals' social &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639768/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Additional qualification &#34;Social medicine&#34; for physicians</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639768-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Social medicine is the medical field that specializes in relationships between health, disease, and society. The goal of social medical care should be to enable functioning and participation in all areas of life as much as possible. Social medicine can be understood as a bridge between individual health care and public health and to other medical specialties. Expertise in social medicine is also helpful for dermatology and in daily clinical practice. This article presents the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639777/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Digital precision medicine in rhythmology : Risk prediction of recurrences, sudden cardiac death, and outcome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639777-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Digital precision medicine is gaining increasing importance in rhythmology, especially in the treatment of cardiac arrhythmias. This trend is driven by the advancing digitization in healthcare and the availability of large amounts of data from various sources such as electrocardiograms (ECGs), implants like pacemakers and implantable cardioverter-defibrillators (ICDs), as well as wearables like smartwatches and fitness trackers. Through the analysis of this data, physicians can develop &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639810/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Functional quality of life among newly diagnosed young adult colorectal cancer survivors compared to older adults: results from the ColoCare Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639810-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: YA CRC survivors reported better physical and worse social function compared to older CRC survivors, and YA CRC survivors were more likely to report clinically meaningful social, role, and physical disfunction. Future work should further investigate QOL using age-relevant benchmarks to inform best practices for CRC survivorship &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38639817/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Nationally standardized broad consent in practice: initial experiences, current developments, and critical assessment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38639817-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: The digitalization in the healthcare sector promises a secondary use of patient data in the sense of a learning healthcare system. For this, the Medical Informatics Initiative&rsquo;s (MII) Consent Working Group has created an ethical and legal basis with standardized consent documents. This paper describes the systematically monitored introduction of these documents at the MII &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38632792/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Transition-state theory reexamined</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38632792-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Two quantum systems, each described as a random-matrix ensemble, are coupled to each other via a number of transition states. Each system is strongly coupled to a large number of channels. The average transmission probability is the product of three factors describing, respectively, formation of the first system from the entrance channel, decay of the second system through the exit channel, and transport through the transition states. Each of the transition states contributes a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38632923/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Heat literacy and adaptation among semi-rural community in Malaysia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38632923-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Heatwaves present health risks globally but there is limited evidence on how temperature perceptions affect activities. This study aimed to examine community perceptions of heat as a potential health hazard and ascertain the current heat protection measures of the residents of the South East Asia Community Observatory (SEACO) in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38633125/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38633125-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Polatuzumab vedotin (Pola) is an approved therapy in combination with rituximab and bendamustine for relapsed or refractory diffuse large B-cell lymphoma (RR-DLBCL) based on positive results of the landmark phase II randomised G029365 trial. However, trial results for many approved novel therapies in RR-DLBCL have not been replicated in routine care cohorts, as RR-DLBCL patient populations are heterogeneous and trial eligibility is increasingly restrictive. We evaluated outcomes from pola &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38633406/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Neuronal-specific methylome and hydroxymethylome analysis reveal significant loci associated with alcohol use disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38633406-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Alcohol use disorder (AUD) is a complex condition associated with adverse health consequences that affect millions of individuals worldwide. Epigenetic modifications, including DNA methylation (5 mC), have been associated with AUD and other alcohol-related traits. Epigenome-wide association studies (EWAS) have identified differentially methylated genes associated with AUD in human peripheral and brain tissue. More recently, epigenetic studies of AUD have also evaluated &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38633883/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Correlation of four-dimensional ultrasound strain analysis with computed tomography angiography wall stress simulations in abdominal aortic aneurysms</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38633883-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The strain and stress analyses provide independent biomechanical information of AAAs. At the current stage of development, the two methods are considered complementary and may optimize a more patient-specific rupture risk prediction in the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38634725/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) survey: Perspectives of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38634725-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The multifaceted challenges identified using the SHAPE survey highlight the global need to improve both patient and caregiver &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38634756/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Strategic thinking in the shadow of self-enhancement: Benefits and costs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38634756-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Using a variant of the hide-and-seek game, we show in three studies that self-enhancement can help or hinder strategic thinking. In this guessing game, one player chooses a number while another player tries to guess it. Each player does this either in a random fashion (throwing a mental die) or by active thinking. The structure of the game implies that guessers benefit from thinking about a number, whereas choosers are disadvantaged. Yet, regardless of their role, respondents prefer to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38634807/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Potential correlation between anti-laminin 332 autoantibodies and malignant tumours in anti-BP180-type mucous membrane pemphigoid</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38634807-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38634919/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Efficacy and safety of the one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38634919-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38634949/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Bilateral sclerochoroidal calcification as an incidental finding</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38634949-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635004/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240418180455&amp;v=2.18.0.post9&#43;e462414">Tissue specific tumor-gene link prediction through sampling based GNN using a heterogeneous network</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635004-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240418180455-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A tissue sample is a valuable resource for understanding a patient&rsquo;s symptoms and health status in relation to tumor growth. Recent research seeks to establish a connection between tissue-specific tumor samples and genetic markers (genes). This breakthrough has paved the way for personalized cancer therapies. With this motivation, the proposed model constructs a heterogeneous network based on tumor sample-gene relation data and gene-gene interaction data. This network also &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635004/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240419180730&amp;v=2.18.0.post9&#43;e462414">Tissue specific tumor-gene link prediction through sampling based GNN using a heterogeneous network</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635004-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240419180730-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A tissue sample is a valuable resource for understanding a patient&rsquo;s symptoms and health status in relation to tumor growth. Recent research seeks to establish a connection between tissue-specific tumor samples and genetic markers (genes). This breakthrough has paved the way for personalized cancer therapies. With this motivation, the proposed model constructs a heterogeneous network based on tumor sample-gene relation data and gene-gene interaction data. This network also &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635019/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635019-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Ultrasound is a powerful diagnostic tool for locoregional melanoma metastasis. However, the real applicability to surveillance programmes is limited by low adherence rates, especially in the US. Further studies should seek to address this adherence &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635086/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Comparison of iCT-based navigation and fluoroscopic-guidance for atlantoaxial screw placement in 78 patients with traumatic cervical spine injuries</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635086-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This study contributes to the available data showing that navigated atlantoaxial screw placement proves to be feasible as well as highly accurate compared to the fluoroscopic-guidance technique without prolonging the time needed for surgery. When comparing these data with other studies, the application of different classification systems for assessment of screw accuracy should be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635088/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">No trauma-related diagnosis in emergency trauma room whole-body computer tomography of patients with inconspicuous primary survey</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635088-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Not one of the clinically asymptomatic patients had an imageable injury after WBCT diagnostics in this study. WBCT should only be performed in severely injured patients after clinical assessment regardless of &ldquo;trauma mechanism.&rdquo; According to guidelines and ATLS®, the clinical examination seems to be a safe and reliable method for reasonable and responsible decision-making regarding the realization of WBCT with all well-known risk &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635174/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">German and Italian validation of the Dyadic Coping Inventory-Sexual Minority Stress (DCI-SMS) scale</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635174-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Lesbian, gay, bisexual, and transgender individuals (hereafter people with minoritized sexual orientation and/or gender identities) have limited legal rights and access to resources because of their marginalized status in society. These limitations are associated with notable health disparities and increase experiences of minority stress. For those in a romantic relationship, being able to communicate and cope with one&rsquo;s partner-dyadic coping-can help buffer stress' deleterious effects &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635192/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">State and trait cognitions differentially affect cyclicity of mood and cortisol in individuals with and without premenstrual dysphoric disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635192-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Premenstrual dysphoric disorder (PMDD) is characterized by a cyclical symptom course. Previous research provides limited findings on possible menstrual-cycle-related psychological and psychoendocrinological processes in PMDD. By using ambulatory assessment (AA), we aimed to compare mood and cortisol cyclicity in individuals with PMDD and healthy controls (HC), and to assess effects of habitual and momentary repetitive negative thinking (RNT) and present moment awareness (PMA) on mood &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635248/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">Treg depletion supercharges ASCT power</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635248-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635248/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Treg depletion supercharges ASCT power</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635248-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635249/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">How lipid coating soothes the gut in AML therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635249-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635249/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">How lipid coating soothes the gut in AML therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635249-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635250/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">HOXA9 and β-catenin safeguard HSC integrity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635250-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635250/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">HOXA9 and β-catenin safeguard HSC integrity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635250-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635251/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">REVEAL puts leukocytes into risk stratification</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635251-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635251/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">REVEAL puts leukocytes into risk stratification</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635251-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635252/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">Matsuoka S, Facchini R, Luis TC, et al. Loss of endothelial membrane KIT ligand affects systemic KIT ligand levels but not bone marrow hematopoietic stem cells. Blood. 2023;142(19):1622-1632</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635252-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635252/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Matsuoka S, Facchini R, Luis TC, et al. Loss of endothelial membrane KIT ligand affects systemic KIT ligand levels but not bone marrow hematopoietic stem cells. Blood. 2023;142(19):1622-1632</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635252-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635253/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">Long-term follow-up for A041202</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635253-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635253/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Long-term follow-up for A041202</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635253-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635254/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">Ibrutinib in CLL: benefit for all?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635254-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635254/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Ibrutinib in CLL: benefit for all?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635254-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635255/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">Which pediatric ITP patients will go on to lupus?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635255-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635255/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Which pediatric ITP patients will go on to lupus?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635255-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635256/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">A challenging case of mast cell sarcoma primarily involving the bone marrow</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635256-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635256/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">A challenging case of mast cell sarcoma primarily involving the bone marrow</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635256-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635257/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240418180453&amp;v=2.18.0.post9&#43;e462414">IFN-γ and CD38 in AML: a T-cell engagement made in heaven?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635257-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240418180453-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635257/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">IFN-γ and CD38 in AML: a T-cell engagement made in heaven?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635257-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635290/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240418180524&amp;v=2.18.0.post9&#43;e462414">Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635290-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240418180524-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Individual sirolimus whole blood concentrations are highly variable, critically influenced by the concomitant use of cytochrome P450 (CYP) 3A inducers or inhibitors, and also modulated by food. Therapeutic drug monitoring is therefore recommended, especially at treatment start or in circumstances that can influence sirolimus exposure. In this case report, we highlight the challenge of achieving therapeutic sirolimus concentrations and present pragmatic solutions with regimen &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635387/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240419180725&amp;v=2.18.0.post9&#43;e462414">Prognosis Prediction of Diffuse Large B-cell Lymphoma in (18)F-FDG PET images Based on Multi-Deep-Learning Models</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635387-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240419180725-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Diffuse large B-cell lymphoma (DLBCL), a cancer of B cells, has been one of the most challenging and complicated diseases because of its considerable variation in clinical behavior, response to therapy, and prognosis. Radiomic features from medical images, such as PET images, have become one of the most valuable features for disease classification or prognosis prediction using learning-based methods. In this paper, a new flexible ensemble deep learning model is proposed for the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635757/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Deletion of mouse lysyl oxidase in megakaryocytes affects bone properties in a sex-dependent manner</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635757-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Lysyl oxidase (LOX) is a facilitator of extracellular matrix cross-linking. Using newly developed megakaryocyte-specific LOX knockout mice, we show that LOX expressed in these scarce bone marrow cells affects bone volume and collagen architecture in a sex-dependent &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635762/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635762-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Axicabtagene ciloleucel (axi-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved for treatment of relapsed/refractory (R/R) large B-cell lymphoma (LBCL). Despite extensive data supporting the use of axi-cel in patients with LBCL, outcomes stratified by race and ethnicity groups are limited. Here, we report clinical outcomes with axi-cel in patients with R/R LBCL by race and ethnicity in both real-world and clinical trial settings. In the real-world &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635762/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240419180722&amp;v=2.18.0.post9&#43;e462414">Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635762-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240419180722-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Axicabtagene ciloleucel (axi-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved for treatment of relapsed/refractory (R/R) large B-cell lymphoma (LBCL). Despite extensive data supporting the use of axi-cel in patients with LBCL, outcomes stratified by race and ethnicity groups are limited. Here, we report clinical outcomes with axi-cel in patients with R/R LBCL by race and ethnicity in both real-world and clinical trial settings. In the real-world &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635764/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Cost-effectiveness of prophylaxis with recombinant versus plasma-derived VWF in severe von Willebrand disease in the US</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635764-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    We evaluated the cost-effectiveness of prophylaxis with rVWF versus with pdVWF for patients with severe VWD. We found that rVWF is a cost-saving factor replacement compared to pdVWF across all willingness-to-pay thresholds in the United &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635773/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Mitochondrial tRNA pseudouridylation governs erythropoiesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635773-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Pseudouridine is the most prevalent RNA modification, and its aberrant function is implicated in various human diseases. However, the specific impact of pseudouridylation on hematopoiesis remains poorly understood. In this study, we investigated the role of tRNA pseudouridylation in erythropoiesis and its association with mitochondrial myopathy, lactic acidosis, and sideroblastic anemia syndrome (MLASA) pathogenesis. By utilizing patient-specific induced pluripotent stem cells (iPSCs) carrying &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635786/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Primary Large B-cell Lymphomas of Immune-Privileged Sites</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635786-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Diffuse large B-cell lymphoma (DLBCL) encompasses a diverse spectrum of aggressive B-cell lymphomas with remarkable genetic heterogeneity and myriad clinical presentations. Multiplatform genomic analyses of DLBCL have identified oncogenic drivers within genetic subtypes that allow for pathologic subclassification of tumors into discrete entities with shared immunophenotypic, genetic, and clinical features. Robust classification of lymphoid tumors establishes a foundation for precision &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635788/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Human Herpesvirus-6 Reactivation and Disease Are Infrequent in Chimeric Antigen Receptor T-cell Therapy Recipients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635788-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Human herpesvirus-6B (HHV-6B) reactivation and disease are increasingly reported after CAR-T-cell therapy (CARTx). HHV-6 reactivation in the CAR-T-cell product was recently reported, raising questions about product and patient management. Due to overlapping manifestations with immune effector cell-associated neurotoxicity syndrome, diagnosing HHV-6B encephalitis is challenging. We provide two lines of evidence assessing the incidence and outcomes of HHV-6B after CARTx. First, in a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38635793/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240419180729&amp;v=2.18.0.post9&#43;e462414">Standardized indolent systemic mastocytosis evaluations across a healthcare system: implications for screening accuracy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38635793-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240419180729-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Timely diagnosis of systemic mastocytosis (SM) remains challenging due to care heterogeneity. We implemented a standardized approach for SM screening and diagnosis utilizing a novel healthcare system-wide international screening registry. A retrospective analysis assessed rates of SM, cutaneous mastocytosis (CM), and molecular diagnoses before and two years after care standardization. Accuracy of individual and combined SM screening tests - basal serum tryptase (BST) ≥11.5 and ≥20.0 ng/mL, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38636414/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240419180725&amp;v=2.18.0.post9&#43;e462414">Prediction of deep molecular response in chronic myeloid leukemia using supervised machine learning models</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38636414-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240419180725-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38636680/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Phosphatidylinositol 4-kinase III alpha governs cytoskeletal organization for invasiveness of liver cancer cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38636680-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: PI4KIIIα regulates cytoskeleton organization via PIK3C2γ/Akt2/paxillin-cofilin to favor migration and invasion of liver cancer cells. These findings provide mechanistic insight into the contribution of PI4KIIIα and HCV to progression of liver cancer and identify promising targets for therapeutic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38636694/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240419180722&amp;v=2.18.0.post9&#43;e462414">An up-conversion fluorescence lateral-flow immunoassay for rapid detection of Daratumumab in serum protein electrophoresis clinical samples</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38636694-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240419180722-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The performance of the up-conversion fluorescence LFA strip meets the purpose of clarifying DARA interference in SPEP results. It may be used as an independent and objective confirmation of the presence of DARA in clinical samples. The LFA strip offers a cost-effective rapid on-site test to check for DARA interference alongside standard SPEP equipment, which significantly improves the interpretation of ambiguous SPEP results involving DARA, and does not intervene the current &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38636702/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Reserpine-induced rat model for depression: Behavioral, physiological and PET-based dopamine receptor availability validation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38636702-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The longitudinal design of the study demonstrated that chronic RES administration induced striatal dopamine depletion that persisted even after the wash-out period. However, the behavior phenotype observed were transient. The data suggest that RES administration can induce a rodent model for depression with mild face &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38636728/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Neutral sphingomyelinase controls acute and chronic alcohol effects on brain activity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38636728-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Alcohol consumption is a widespread phenomenon throughout the world. However, how recreational alcohol use evolves into alcohol use disorder (AUD) remains poorly understood. The Smpd3 gene and its coded protein neutral sphingomyelinase (NSM) are associated with alcohol consumption in humans and alcohol-related behaviors in mice, suggesting a potential role in this transition. Using multiparametric magnetic resonance imaging, we characterized the role of NSM in acute and chronic effects &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38636886/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Early life adversities are associated with lower expected value signaling in the adult brain</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38636886-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our results suggested that early adverse experiences in caregiver context might have a long-term disruptive effect on reward learning in reward-related brain regions, which can be associated with suboptimal decision-making and thereby may increase the vulnerability of developing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38637127/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Cavitron ultrasonic surgical aspirator (CUSA) compared with conventional pancreatic transection in distal pancreatectomy: study protocol for the randomised controlled CUSA-1 pilot trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38637127-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Postoperative pancreatic fistula (POPF) remains the most common and serious complication after distal pancreatectomy. Many attempts at lowering fistula rates have led to unrewarding insignificant results as still up to 30% of the patients suffer from clinically relevant POPF. Therefore, the development of new innovative methods and procedures is still a cornerstone of current surgical research.The cavitron ultrasonic surgical aspirator (CUSA) device is a well-known &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38637494/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Membrane to cortex attachment determines different mechanical phenotypes in LGR5&#43; and LGR5- colorectal cancer cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38637494-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Colorectal cancer (CRC) tumors are composed of heterogeneous and plastic cell populations, including a pool of cancer stem cells that express LGR5. Whether these distinct cell populations display different mechanical properties, and how these properties might contribute to metastasis is poorly understood. Using CRC patient derived organoids (PDOs), we find that compared to LGR5- cells, LGR5+ cancer stem cells are stiffer, adhere better to the extracellular matrix (ECM), move slower both &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38637518/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Detecting m&lt;sup&gt;6&lt;/sup&gt;A at single-molecular resolution via direct RNA sequencing and realistic training data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38637518-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Direct RNA sequencing offers the possibility to simultaneously identify canonical bases and epi-transcriptomic modifications in each single RNA molecule. Thus far, the development of computational methods has been hampered by the lack of biologically realistic training data that carries modification labels at molecular resolution. Here, we report on the synthesis of such samples and the development of a bespoke algorithm, mAFiA (m⁶A Finding Algorithm), that accurately detects single &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38637689/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38637689-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Clonal hematopoiesis (CH) driven by mutations in the DNA damage response (DDR) pathway is frequent in patients with cancer and is associated with a higher risk of therapy-related myeloid neoplasms (t-MNs). Here, we analyzed 423 serial whole blood and plasma samples from 103 patients with relapsed high-grade ovarian cancer receiving carboplatin, poly(ADP-ribose) polymerase inhibitor (PARPi) and heat shock protein 90 inhibitor (HSP90i) treatment within the phase II EUDARIO trial &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38637703/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240419180738&amp;v=2.18.0.post9&#43;e462414">Luciferase- and HaloTag-based reporter assays to measure small-molecule-induced degradation pathway in living cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38637703-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240419180738-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The rational development of small-molecule degraders (e.g., proteolysis targeting chimeras) remains a challenge as the rate-limiting steps that determine degrader efficiency are largely unknown. Standard methods in the field of targeted protein degradation mostly rely on classical, low-throughput endpoint assays such as western blots or quantitative proteomics. Here we applied NanoLuciferase- and HaloTag-based screening technologies to determine the kinetics and stability &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pypi.org/project/label-studio/1.12.0/">1.12.0</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/pypi-org-project-label-studio-1-12-0/">
    
    
    
    
    
      
    
    Label Studio annotation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OalXBlyPI">最近看到一些朋友私信或者微信讨论。他们都移民到了加拿大、大洋洲、欧洲、日本或新加坡等国。他们都不约而同地说美国不是他们最先考虑的移民国家，首要原因是因...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oalxblypi/">
    
    
    
    
    
      
    
    最近看到一些朋友私信或者微信讨论。他们都移民到了加拿大、大洋洲、欧洲、日本或新加坡等国。他们都不约而同地说美国不是他们最先考虑的移民国家，首要原因是因为美国H1b-绿卡移民太难了，除此以外枪支泛滥、社会太卷（工作/生活比例失衡）以及文化保守和歧视也是重要原因。但他们基本都说他们最终还是希望能够移民美国的，最重要的原因还是因为美国工资高、工作多，各个公司都是本领域顶尖；以及大学教育好。还有一个很重要的原因是因为很多人在国内的成长过程中受美国文化影响很深，即使接受的很多是负面宣传，但这让他们反而对美国充满了好奇，甚至充满了吸引。<!-- raw HTML omitted --><!-- raw HTML omitted -->这些评论首先让我想起了各个酒吧里经常放的两首歌Britney - Toxic，和Amy Winehouse - You Know &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OaljL1O7S">🔻怎么评价这种行为？🔻源：《以色列时报》官网 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oaljl1o7s/">
    
    
    
    
    
      
    
    🔻怎么评价这种行为？<!-- raw HTML omitted -->🔻源：《以色列时报》官网 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OallypDri">🔻塔斯社官网统计：本次春汛俄罗斯已有 1.8 万栋住宅楼被淹没。数字还在不断增加，涉及奥伦堡、库尔干、秋明、托木斯克、萨马拉、巴什基里亚和阿尔泰等地区。 ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oallypdri/">
    
    
    
    
    
      
    
    🔻塔斯社官网统计：本次春汛俄罗斯已有 1.8 万栋住宅楼被淹没。数字还在不断增加，涉及奥伦堡、库尔干、秋明、托木斯克、萨马拉、巴什基里亚和阿尔泰等地区。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OalnM5wZu">🔻似它！道具大师（ ）🔻我怀疑纸上的每个字母有1厘米大，没讲两句话就要翻页。🔻这会儿联合国官网正在直播。 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oalnm5wzu/">
    
    
    
    
    
      
    
    🔻似它！道具大师（ ）<!-- raw HTML omitted -->🔻我怀疑纸上的每个字母有1厘米大，没讲两句话就要翻页。<!-- raw HTML omitted -->🔻这会儿联合国官网正在直播。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OalpqtKgm">🔻狂野八十年代。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oalpqtkgm/">
    
    
    
    
    
      
    
    🔻狂野八十年代。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OalrDuHMi">🔻弃权王国代表上来就强烈谴责伊朗，“伊朗的行动没有任何用处”。🔻源：联合国官方媒体服务。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oalrduhmi/">
    
    
    
    
    
      
    
    🔻弃权王国代表上来就强烈谴责伊朗，“伊朗的行动没有任何用处”。<!-- raw HTML omitted -->🔻源：联合国官方媒体服务。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OalsW5uOb">🔻熟悉的高铁餐车布局，不熟悉的餐车菜单。 [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oalsw5uob/">
    
    
    
    
    
      
    
    🔻熟悉的高铁餐车布局，不熟悉的餐车菜单。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oalvnp5z1">🔻发表在乌克兰国防部官方网站上的一篇新闻稿显示：“乌克兰已采取重大措施，在军队中落实性别平等原则。我们正在引入使用性别敏感语言的新规则，努力为在军队...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oalvnp5z1/">
    
    
    
    
    
      
    
    🔻发表在乌克兰国防部官方网站上的一篇新闻稿显示：“乌克兰已采取重大措施，在军队中落实性别平等原则。我们正在引入使用性别敏感语言的新规则，努力为在军队中，特别是在领导和战斗岗位上落实女性平等创造条件。我们将继续利用西方的最佳经验在军队中实施性别政策。”<!-- raw HTML omitted -->🔻是的，乌克兰准备以“实现性别平等”的理由，动员乌克兰妇女进入“战斗岗位”。<!-- raw HTML omitted -->🔻版本太先进了。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OalxKfD41">🔻《斯穆格连卡舞曲》🔻晚安。 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oalxkfd41/">
    
    
    
    
    
      
    
    🔻《斯穆格连卡舞曲》<!-- raw HTML omitted -->🔻晚安。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/EmZTfEJolx08ebIi0A1W0104120078g">https://f.video.weibocdn.com/o0/EmZTfEJolx08ebIi0A1W0104120078g</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oalyc4usx">🔻正在直播傅大使发言。🔻“战争正在考验公平正义，和平呼吁理性和担当。”🔻源：联合国官方媒体服务。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oalyc4usx/">
    
    
    
    
    
      
    
    🔻正在直播傅大使发言。<!-- raw HTML omitted -->🔻“战争正在考验公平正义，和平呼吁理性和担当。”<!-- raw HTML omitted -->🔻源：联合国官方媒体服务。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OalyMmSmK">🔻啊，孙参赞侧颜杀。🔻源：联合国官方媒体服务。 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oalymmsmk/">
    
    
    
    
    
      
    
    🔻啊，孙参赞侧颜杀。<!-- raw HTML omitted -->🔻源：联合国官方媒体服务。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/Oag4kuU4t">兜兜转转我也会做预知梦了哈😊可真是恶心</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-oag4kuu4t/">
    
    
    
    
    
      
    
    兜兜转转我也会做预知梦了哈😊<!-- raw HTML omitted -->可真是恶心  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/Oah2ylePU">能碰到这样的hr我……我忍了[苦涩][苦涩][苦涩] - 转发 @德云社李鹤东:&amp;ensp;#万春逗笑社今日开播# 那我开了你，怎么不算帮了你呢？#万春逗笑社# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-oah2ylepu/">
    
    
    
    
    
      
    
    能碰到这样的hr我……我忍了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[苦涩]&quot; src=&ldquo;<a href="https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/7e/2021_bitter_org.png%22">https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/7e/2021_bitter_org.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/OahbgvOR9">[鲜花][鲜花][鲜花][春游家族][春游家族] - 转发 @小杨钟意李-:&amp;ensp;李鹤东小李总第一集cut 小杨钟意李-的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-oahbgvor9/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[春游家族]&quot;  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OafGwFORP">今天上海这天气绝对是凤凰开大了👿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-oafgwforp/">
    
    
    
    
    
      
    
    今天上海这天气绝对是凤凰开大了👿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OajfbyqLH">今天大老爷对哈根达斯a上面有两个点表示了强烈谴责👿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-oajfbyqlh/">
    
    
    
    
    
      
    
    今天大老爷对哈根达斯a上面有两个点表示了强烈谴责👿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OafNh5ZBD">//@顶筆TEN使:久保史绪里🤓 - 转发 @長亭梅:&amp;ensp;梅泽美波#梅泽美波# 2024.04.11 手机mail「呀吼」&lt;图&gt;感谢大家收听昨晚的all night日本〜！很开心，没聊够呢...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oafnh5zbd/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->🤓<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@長亭梅<!-- raw HTML omitted -->: &lt;a href=&ldquo;<a href="https://m.weibo.cn/p">https://m.weibo.cn/p</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OagPUat9F">好无聊</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oagpuat9f/">
    
    
    
    
    
      
    
    好无聊  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OagXBzFgd">不许看全都不许看😭😭😭👊🏻👊🏻👊🏻👊🏻👊🏻//@白白逗猴莉:你们不许看！！！[怒]//@詩紫山下·Meteor:这不可以吧😇 - 转发 @山下...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oagxbzfgd/">
    
    
    
    
    
      
    
    不许看全都不许看😭😭😭👊🏻👊🏻👊🏻👊🏻👊🏻//<!-- raw HTML omitted -->@白白逗猴莉<!-- raw HTML omitted -->:你们不许看！！！<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@詩紫山下·Meteor<!-- raw HTML omitted -->:这不可以吧😇<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@山下美月教会<!-- raw HTML omitted -->: &lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E5%B1%B1%E4%B8%8B%E7%BE%8E">https://m.weibo.cn/p/index?extparam=%E5%B1%B1%E4%B8%8B%E7%BE%8E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OagXs313i">好喜欢和姐姐妹妹在一起的生活很放松很开心，随心所欲</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oagxs313i/">
    
    
    
    
    
      
    
    好喜欢和姐姐妹妹在一起的生活<!-- raw HTML omitted -->很放松很开心，随心所欲  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OahnAvwjm">对我cp：我视奸你们很累，你们能自觉告诉我今天聊天了吗？说了什么话？有没有想彼此，想了多少次？你们能告诉我吗？你们怎么在一起，你们的过往、童年、家庭、生...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oahnavwjm/">
    
    
    
    
    
      
    
    对我cp：我视奸你们很累，你们能自觉告诉我今天聊天了吗？说了什么话？有没有想彼此，想了多少次？你们能告诉我吗？你们怎么在一起，你们的过往、童年、家庭、生活，这些我全要知道。在认识彼此之前你们认识谁？这些我也要知道。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OaiyHua8Y">们宅宅真严格啊</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oaiyhua8y/">
    
    
    
    
    
      
    
    们宅宅真严格啊  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OajSdAZzx">们家大人还在疑惑为什么最近护照不让办出国要报备当然是因为我们省偷渡第一名啦🤗</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oajsdazzx/">
    
    
    
    
    
      
    
    们家大人还在疑惑为什么最近护照不让办出国要报备<!-- raw HTML omitted -->当然是因为我们省偷渡第一名啦🤗  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OajVHlRGI">转发微博 - 转发 @向井葉月_向日葵official:&amp;ensp;向井叶月#向井叶月# 4/18 12:04「向井葉月message」 会在17:45～(北京时间16:45～)在文化放送播出的「高桥将市...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oajvhlrgi/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@向井葉月_向日葵official<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->向井叶月<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%252">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OakCO00M5">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.17官网 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oakco00m5/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.17官网 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hovaglvncrj315o1jah1w.jpg%22">https://tvax1.sinaimg.cn/large/006z6nxLgy1hovaglvncrj315o1jah1w.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oam4ECUt9">好像是以一种所谓旁观者的角度而存在于这个世界上最近总是觉得周遭的环境事物都与我无关但又见证着一个又一个故事的诞生很奇妙，有些自以为是的认为是很有思想的...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oam4ecut9/">
    
    
    
    
    
      
    
    好像是以一种所谓旁观者的角度而存在于这个世界上<!-- raw HTML omitted -->最近总是觉得周遭的环境事物都与我无关<!-- raw HTML omitted -->但又见证着一个又一个故事的诞生<!-- raw HTML omitted -->很奇妙，有些自以为是的认为是很有思想的在活着<!-- raw HTML omitted -->实际上被忘记也就是一呼一吸之间的事<!-- raw HTML omitted --><!-- raw HTML omitted -->有趣得很  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OafwxtHLS">的確是這樣的[太开心] - 转发 @多次婉拒久保织织:&amp;ensp;推久保史绪里，过少爷生活[老师爱你] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oafwxthls/">
    
    
    
    
    
      
    
    的確是這樣的<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@多次婉拒久保织织<!-- raw HTML omitted -->: 推久保史绪里，过少爷生活<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/005LMJWfgy1houf0">https://tvax3.sinaimg.cn/large/005LMJWfgy1houf0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OalnGDvds">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.gekicine X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oalngdvds/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.gekicine X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hounsvoqbnj31p414re81.jpg%22">https://tvax4.sinaimg.cn/large/006z6nxLgy1hounsvoqbnj31p414re81.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OaimIkubd">时隔62年，终于出现又一位挑战本因坊的关西棋院棋手#围棋#围棋</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-oaimikubd/">
    
    
    
    
    
      
    
    时隔62年，终于出现又一位挑战本因坊的关西棋院棋手<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OaltqzQRW">发布了头条文章：《新布局革命和田中不二男——日本围棋百大奠基人012》 #围棋# 围棋 新布局革命和田中不二男——日本围棋百大奠基人012 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-oaltqzqrw/">
    
    
    
    
    
      
    
    发布了头条文章：《新布局革命和田中不二男——日本围棋百大奠基人012》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Oaly42tW2">棋手战鹰磕磕绊绊也361天了 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-oaly42tw2/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted -->磕磕绊绊也361天了 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OafhqvzRZ">久保史绪里via.gekicine X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oafhqvzrz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.gekicine X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OafKBqdX2">久保史绪里 - 转发 @YodaChannel:&amp;ensp;与田祐希 #与田祐希# 2024.04.18 08:46久违的上了ANN！感觉转瞬即逝！ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oafkbqdx2/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@YodaChannel<!-- raw HTML omitted -->: &lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E4%B8%8E%E7%94%B0%E7%A5%90%E5%B8%8C&amp;amp;containerid=1008081">https://m.weibo.cn/p/index?extparam=%E4%B8%8E%E7%94%B0%E7%A5%90%E5%B8%8C&amp;amp;containerid=1008081</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OafKPuyWf">久保史绪里🤓 - 转发 @長亭梅:&amp;ensp;梅泽美波#梅泽美波# 2024.04.11 手机mail「呀吼」&lt;图&gt;感谢大家收听昨晚的all night日本〜！很开心，没聊够呢 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oafkpuywf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->🤓<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@長亭梅<!-- raw HTML omitted -->: &lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E6%A2%85%E6%B3%BD%E7%BE%8E%E6%B3%A2&amp;amp;containerid=100808">https://m.weibo.cn/p/index?extparam=%E6%A2%85%E6%B3%BD%E7%BE%8E%E6%B3%A2&amp;amp;containerid=100808</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OakrA99LO">久保史绪里via.17官网 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oakra99lo/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.17官网 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hovaljiptoj31">https://tvax2.sinaimg.cn/large/006z6nxLgy1hovaljiptoj31</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Oajkl0hJB">柯洁#2024lg杯选拔赛##赛事预告# 第29届LG杯世界围棋棋王战中国代表选拔赛第二阶段将于明天上午十点在浙江衢州进行，柯洁九段对阵檀啸九段。柯柯加油！[加油][加...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oajkl0hjb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1JD421H7VT">中东冲突是否会升级？最大的变量是黎巴嫩真主党</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1jd421h7vt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/04/18/1198908720/ralph-nader-consumer-crusader">Ralph Nader, Consumer Crusader</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-04-18-1198908720-ralph-nader-consumer-crusader/">
    
    
    
    
    
      
    
    Whether it&rsquo;s pesticides in your cereal or the door plug flying off your airplane, consumers today have plenty of reasons to feel like corporations might not have their best interests at heart. At a moment where we&rsquo;re seeing unprecedented product recalls, and when trust in the government is near historic lows, we&rsquo;re going to revisit a time when a generation of people felt empowered to demand accountability from both companies and elected leaders — and got results. Today on the show, the story of the U.S. consumer movement and its controversial leader: the once famous, now infamous Ralph &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/437097728/answer/3470380032">猫哥的视界回答了问题: 宋朝的「岁币买平安」是一项高明的政治策略吗？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-437097728-answer-3470380032/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/648902983/answer/3470420093">猫哥的视界回答了问题: 甲午战争清朝陆军装备可不弱，比日本强，为什么却输的一败涂地？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-648902983-answer-3470420093/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/693257987">量子位发表了文章: 万字梳理中国AIGC产业峰会激辩，大模型应用最全行业参考在此</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-693257987/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/693267870">量子位发表了文章: Sora问世，如何用大模型反诈？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-693267870/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/693268913">量子位发表了文章: 波士顿动力Atlas停止研发！新一代人形机器人转投电驱动方案</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-693268913/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/693298315">量子位发表了文章: Llama 3突然来袭！开源社区再次沸腾：GPT-4级别模型可以自由访问的时代到来</a></h1>
  <div class="date-author">
    
    <span class="date">2024-04-18</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-693298315/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

